Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3)

Controlled trials to assess approved SARS-CoV-2 vaccines in immunocompromised patients: Third sub-protocol for an observational study comparing benefits and potential risks of the newly approved bivalent SARS-CoV-2 vaccines